Form D · Other Health Care

Neuralieve, Inc.

Sunnyvale, CA · CIK 0001477913

Offering snapshot reported Dec 10, 2010 · SEC filing

Reported sold
$7.48M
Offering amount: $15.5M
Investors reported
25
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 30, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.74M$7.48MJan 11, 2010: $3,890,652.00Jan 11, 2010Dec 10, 2010: $7,481,174.00Dec 10, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,890,652 → $7,481,174
  • Reported investors24 → 25

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 10, 2010Amendment$7,481,174$3,590,522vs Jan 11, 201025SEC filing
Jan 11, 2010Initial$3,890,652No comparison24SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-137660

Source: Form D, filed Dec 10, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Terese Baker Executive
Annette Campbell White Director
David Fischell Director
Robert Fischell Director, Executive
Frank Fisher Director
Mark Lortz Director
Ting Lu Executive
Carol Schembri Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
240 N. Wolfe Road
Sunnyvale, CA, 94085